Lilly to Participate in Guggenheim Oncology Conference

Rhea-AI Summary

Eli Lilly and Company (NYSE: LLY) will participate in the Guggenheim Oncology Conference on February 9, 2023. Key executives, including Jacob Van Naarden, CEO of Loxo@Lilly, and Dr. David Hyman, Chief Medical Officer, will engage in a fireside chat at 10:10 a.m. Eastern Time.

A live audio webcast of the event can be accessed through the 'Webcasts & Presentations' section on Lilly's Investor website. A replay will be available for 30 days after the event. Lilly has been at the forefront of medical innovations for nearly 150 years, focusing on life-changing therapies and ensuring accessibility for millions globally.

INDIANAPOLIS, Feb. 3, 2023 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will participate in the Guggenheim Oncology Conference on Thursday, Feb. 9, 2023. Jacob Van Naarden, executive vice president and CEO, Loxo@Lilly and David Hyman, M.D., chief medical officer, Loxo@Lilly, will participate in a fireside chat at 10:10 a.m., Eastern time.

A live audio webcast will be available on the "Webcasts & Presentations" section of Lilly's Investor website at https://investor.lilly.com/webcasts-and-presentations. A replay of the presentation will be available on this same website for approximately 30 days.

About Lilly

Lilly unites caring with discovery to create medicines that make life better for people around the world. We've been pioneering life-changing discoveries for nearly 150 years, and today our medicines help more than 47 million people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world's most significant health challenges, redefining diabetes care, treating obesity and curtailing its most devastating long-term effects, advancing the fight against Alzheimer's disease, providing solutions to some of the most debilitating immune system disorders, and transforming the most difficult-to-treat cancers into manageable diseases. With each step toward a healthier world, we're motivated by one thing: making life better for millions more people. That includes delivering innovative clinical trials that reflect the diversity of our world and working to ensure our medicines are accessible and affordable. To learn more, visit Lilly.com and Lilly.com/newsroom or follow us on Facebook, Instagram and LinkedIn. F-LLY

Refer to:	Jordan Bishop; jordan.bishop@lilly.com; 317-473-5712 (Media)
	Joe Fletcher; jfletcher@lilly.com; 317-296-2884 (Investors)

 

 

 

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/lilly-to-participate-in-guggenheim-oncology-conference-301737770.html

SOURCE Eli Lilly and Company

FAQ

What date is Eli Lilly participating in the Guggenheim Oncology Conference?

Eli Lilly will participate in the Guggenheim Oncology Conference on February 9, 2023.

Who from Eli Lilly will speak at the Guggenheim Oncology Conference?

Jacob Van Naarden and Dr. David Hyman from Eli Lilly will speak at the conference.

What time is Eli Lilly's presentation at the Guggenheim Oncology Conference?

Eli Lilly's presentation is scheduled for 10:10 a.m. Eastern Time.

Where can I watch Eli Lilly's presentation from the conference?

You can watch the presentation live on Lilly's Investor website in the 'Webcasts & Presentations' section.

How long will the replay of Eli Lilly's presentation be available?

The replay of Eli Lilly's presentation will be available for approximately 30 days.